Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Apr, 2019 | Pages:
153 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global epigenetics diagnostic market size is expected to reach USD 21.7 billion by 2026, expanding at a CAGR of 18.8% over the forecast period, according to a new study by Grand View Research, Inc. Growing prevalence of cancer and other diseases across the globe, along with epigenetic modification base, is anticipated to fuel the industry growth during the forecast period. Diagnostic companies are upgrading their products by implementing new techniques for attaining specific and sensitive results. Companies such as Abcam plc, Invitrogen, and Sigma Aldrich Corporation are developing a new range of Chromatin immunoprecipitation (ChIP)-validated antibodies specific for detection of histone modifications at various loci. In addition, many biotechnology and pharmaceutical companies and academic research organizations are collaborating to promote the growth of the epigenetics diagnostic industry. Companies such as Epigenomics, OncoMethylome Sciences, and Orion Genomics have collaborated with other laboratories and diagnostic companies that have licensed their technology for development of Laboratory-developed Tests (LDTs). Technological advancements resulting in increased accuracy, portability, and cost-effectiveness are expected to be a high-impact rendering driver in the market. For instance, Diagenode has developed automated kits for detection and purification of methylated DNA. Further key findings from the study suggest: • On the basis of product, reagents held the largest share owing to increasing R&D activities in field of epigenetics. Kits are expected to witness high demand over the forecast period, expanding at a CAGR of 19.2% due to need for rapid and accurate detection techniques • Based on technology, DNA methylation held a major share in terms of revenue in 2018. Technological advancements such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve diagnostics efficiency are the factors attributing to its largest share • Growing prevalence of cancer with epigenetic modification is a key factor driving the oncology application segment. Solid tumors further dominated the segment in 2018 • North America emerged as a major regional market in 2018 due to factors such as high levels of patient awareness, growing collaborations between large pharmaceutical firms for development of improved therapeutics, increasing funding for R&D, and increasing cancer prevalence • The market in Asia Pacific is estimated to witness significant growth over the forecast period with a CAGR of 20.9% owing to the presence of large target population having cancer, diabetes, and other chronic disorders, along with parallel unmet clinical needs • Major players of the industry include Sigma-Aldrich Corporation; Valirx Plc; Oncolys Biopharma Inc.; Zymo Research Corporation; Qiagen; Thermo Fisher Scientific; Diagenode Diagnostics; and Illumina, Inc. Extensive R&D initiatives for development of novel drugs and presence of strong product pipeline are expected to further boost the market growth over the forecast period.
Table of Contents
Chapter 1 Research methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
i. Purchased database
ii. GVR's internal database
iii. Secondary sources & third-party perspectives
iv. Primary research
1.4 Information analysis
i. Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive summary
2.1 Epigenetics Diagnostic Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Global Epigenetics Diagnostic Market Variables, Trends & Scope
3.1 Penetration & Growth Prospects Mapping
3.2 Regulatory Framework
3.2.1 Reimbursement framework
3.2.2 Standards & Compliances
3.3 Epigenetics Diagnostic Market Dynamics
3.3.1 Epigenetics Diagnostic Market Driver Analysis
3.3.1.1 Increasing prevalence of target diseases
3.3.1.2 Growing global geriatric population
3.3.1.3 Presence of funding programs to promote and support research & development
3.3.1.4 Technological advancements
3.3.2 Epigenetics Diagnostic Market Restraint Analysis
3.3.2.1 Inefficiency in identification and validation of biomarkers
3.3.2.2 Presence of complex regulatory framework
3.4 Global Epigenetics Diagnostic Market Analysis Tool
3.4.1 Industry Analysis - Porter's
3.4.1.1 Supplier power (Low due to many manufacturers for diagnostic reagents)
3.4.1.2 Buyer power (Moderate due to various manufacturers in the market)
3.4.1.3 Substitution threat (Moderate due to introduction of new diagnostic kits)
3.4.1.4 New entrants threat (High due to high demand for novel techniques)
3.4.1.5 Competitive rivalry (High due to increasing acquisitions by players)
3.4.2 Epigenetics Diagnostic Market - SWOT by PEST Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.3.1 Joint Ventures
3.4.3.2 Mergers & Acquisitions
3.4.3.3 Licensing & Partnership
3.4.3.4 Technology Collaborations
3.4.3.5 Strategic Divestments Company market share analysis
Chapter 4 Global Epigenetics Diagnostic Market - Competitive Analysis
4.1 Recent developments & impact analysis, by key market participants
4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.4.2 Company Market Share
4.4.3 Competitive Dashboard Analysis
4.4.4 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Regional network map
4.5.3 Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5 Global Epigenetics Diagnostic Market: Product Estimates & Trend Analysis
5.1 Definition & Scope
5.2 Product market share analysis, 2018 & 2026
5.3 Global Epigenetics Diagnostic Market, by Product, 2014 to 2026
5.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
5.4.1 Epigenetics-based reagents market
5.4.1.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
5.4.2 Epigenetics-based kits market
5.4.2.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
5.4.2.2 ChIP sequencing kit market
5.4.2.2.1 ChIP sequencing kit market, 2014 to 2026 (USD Million)
5.4.2.3 Whole-genomic amplification kit market
5.4.2.3.1 Whole-genomic amplification kit market, 2014 to 2026 (USD Million)
5.4.2.4 Bisulfite conversion kit market
5.4.2.4.1 Bisulfite conversion kit market, 2014 to 2026 (USD Million)
5.4.2.5 RNA sequencing Kit market
5.4.2.5.1 RNA sequencing Kit market, 2014 to 2026 (USD Million)
5.4.2.6 Others market
5.4.2.6.1 Others market, 2014 to 2026 (USD Million)
5.4.3 Epigenetics-based instruments market
5.4.3.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
5.4.4 Epigenetics-based enzymes market
5.4.4.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
5.4.5 Epigenetics-based services market
5.4.5.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
Chapter 6 Global Epigenetics Diagnostic Market: Technology Estimates & Trend Analysis
6.1 Definition & Scope
6.2 Technology market share analysis, 2018 & 2026
6.3 Global Epigenetics Diagnostic Market, by Technology, 2014 to 2026
6.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
6.4.1 Epigenetics-based DNA methylation market
6.4.1.1 Epigenetics-based DNA methylation market,2014 to 2026 (USD Million)
6.4.1.2 Epigenetics-based reagents market
6.4.1.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.1.3 Epigenetics-based kits market
6.4.1.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.1.4 Epigenetics-based instruments market
6.4.1.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.1.5 Epigenetics-based enzymes market
6.4.1.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.1.6 Epigenetics-based services market
6.4.1.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.2 Epigenetics-based histone methylation market
6.4.2.1 Epigenetics-based histone methylation market revenue (USD Million)
6.4.2.2 Epigenetics-based reagents market
6.4.2.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.2.3 Epigenetics-based kits market
6.4.2.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.2.4 Epigenetics-based instruments market
6.4.2.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.2.5 Epigenetics-based enzymes market
6.4.2.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.2.6 Epigenetics-based services market
6.4.2.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.3 Epigenetics-based histone acetylation market
6.4.3.1 Epigenetics-based enzymes Market revenue (USD Million)
6.4.3.2 Epigenetics-based reagents market
6.4.3.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.3.3 Epigenetics-based kits market
6.4.3.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.3.4 Epigenetics-based instruments market
6.4.3.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.3.5 Epigenetics-based enzymes market
6.4.3.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.3.6 Epigenetics-based services market
6.4.3.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.4 Epigenetics-based long non-coding RNA market
6.4.4.1 Epigenetics-based long non-coding RNA market revenue (USD Million)
6.4.4.2 Epigenetics-based reagents market
6.4.4.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.4.3 Epigenetics-based kits market
6.4.4.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.4.4 Epigenetics-based instruments market
6.4.4.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.4.5 Epigenetics-based enzymes market
6.4.4.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.4.6 Epigenetics-based services market
6.4.4.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.5 Epigenetics-based microRNA modification market
6.4.5.1 Epigenetics-based microRNA modification market revenue (USD Million)
6.4.5.2 Epigenetics-based reagents market
6.4.5.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.5.3 Epigenetics-based kits market
6.4.5.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.5.4 Epigenetics-based instruments market
6.4.5.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.5.5 Epigenetics-based enzymes market
6.4.5.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.5.6 Epigenetics-based services market
6.4.5.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
6.4.6 Epigenetics-based chromatin structures market
6.4.6.1 Epigenetics-based chromatin structures market revenue (USD Million)
6.4.6.2 Epigenetics-based reagents market
6.4.6.2.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
6.4.6.3 Epigenetics-based kits market
6.4.6.3.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
6.4.6.4 Epigenetics-based instruments market
6.4.6.4.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
6.4.6.5 Epigenetics-based enzymes market
6.4.6.5.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
6.4.6.6 Epigenetics-based services market
6.4.6.6.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
Chapter 7 Global Epigenetics Diagnostic Market: Application Estimates & Trend Analysis
7.1 Definition & Scope
7.2 Application market share analysis, 2018 & 2026
7.3 Global Epigenetics Diagnostic Market, by Application 2014 to 2026
7.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
7.4.1 Oncology market
7.4.1.1 Oncology market, 2014 to 2026 (USD Million)
7.4.1.2 Solid tumors market
7.4.1.2.1 Solid tumors market, 2014 to 2026 (USD Million)
7.4.1.3 Liquid tumors market
7.4.1.3.1 Liquid tumors market, 2014 to 2026 (USD Million)
7.4.2 Non-Oncology market
7.4.2.1 Non-Oncology market, 2014 to 2026 (USD Million)
7.4.2.2 Inflammatory disease market
7.4.2.2.1 Inflammatory disease market, 2014 to 2026 (USD Million)
7.4.2.3 Metabolic diseases kit market
7.4.2.3.1 Metabolic diseases market, 2014 to 2026 (USD Million)
7.4.2.4 Infectious diseases market
7.4.2.4.1 Infectious diseases market, 2014 to 2026 (USD Million)
7.4.2.5 Cardiovascular diseases market
7.4.2.5.1 Cardiovascular diseases market, 2014 to 2026 (USD Million)
7.4.2.6 Others market
7.4.2.6.1 Others market, 2014 to 2026 (USD Million)
Chapter 8 Global Epigenetics Diagnostic Market: Regional Estimates & Trend Analysis, by Product, Technology & Application
8.1 Global Epigenetics Diagnostic Market: Regional Movement Analysis, 2018 & 2026
8.2 Global IVD Market: Leading Players, 2018:
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa
8.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 North America
8.4.1 North America Epigenetics Diagnostic Market, 2014 - 2026 (USD Million)
8.4.2 U.S. Epigenetics Diagnostic Market
8.4.2.1 U.S. Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.4.3 Canada Epigenetics Diagnostic Market
8.4.3.1 Canada Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5 Europe
8.5.1 Europe Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.2 Germany Epigenetics Diagnostic Market
8.5.2.1 Germany Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.3 U.K. Epigenetics Diagnostic Market
8.5.3.1 U.K. Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.4 Spain Epigenetics Diagnostic Market
8.5.4.1 Spain Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.5 France Epigenetics Diagnostic Market
8.5.5.1 France Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.6 Italy Epigenetics Diagnostic Market
8.5.6.1 Italy Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.5.7 Russia Epigenetics Diagnostic Market
8.5.7.1 Russia Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.2 Japan Epigenetics Diagnostic Market
8.6.2.1 Japan Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.3 China Epigenetics Diagnostic Market
8.6.3.1 China Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.4 India Epigenetics Diagnostic Market
8.6.4.1 India Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.5 South Korea Epigenetics Diagnostic Market
8.6.5.1 South Korea Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.6 Singapore Epigenetics Diagnostic Market
8.6.6.1 Singapore Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.6.7 Australia Epigenetics Diagnostic Market
8.6.7.1 Australia Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7 Latin America
8.7.1 Latin America Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7.2 Brazil Epigenetics Diagnostic Market
8.7.2.1 Brazil Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7.3 Mexico Epigenetics Diagnostic Market
8.7.3.1 Mexico Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.7.4 Argentina Epigenetics Diagnostic Market
8.7.4.1 Argentina Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8 MEA
8.8.1 MEA Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8.2 South Africa Epigenetics Diagnostic Market
8.8.2.1 South Africa Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8.3 UAE Epigenetics Diagnostic Market
8.8.3.1 UAE Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
8.8.4 Saudi Arabia Epigenetics Diagnostic Market
8.8.4.1 Saudi Arabia Epigenetic Diagnostic Market, 2014 - 2026 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Company Profiles
9.2.1 Illumina, Inc.
9.2.1.1 Overview
9.2.1.2 Financial performance
9.2.1.3 Strategic initiatives
9.2.1.4 Product benchmarking
9.2.2 Merck Sharp & Dohme Corp
9.2.2.1 Overview
9.2.2.2 Financial performance
9.2.2.3 Strategic initiatives
9.2.2.4 Product benchmarking
9.2.3 Qiagen
9.2.3.1 Overview
9.2.3.2 Financial performance
9.2.3.3 Strategic initiatives
9.2.3.4 Product benchmarking
9.2.4 F. Hoffmann-La Roche Ltd.
9.2.4.1 Overview
9.2.4.2 Financial performance
9.2.4.3 Strategic initiatives
9.2.4.4 Product benchmarking
9.2.5 Abcam plc
9.2.5.1 Overview
9.2.5.2 Financial performance
9.2.5.3 Strategic initiatives
9.2.5.4 Product benchmarking
9.2.6 Diagenode Diagnostics
9.2.6.1 Overview
9.2.6.2 Financial performance
9.2.6.3 Strategic initiatives
9.2.6.4 Product benchmarking
9.2.7 Thermo Fisher Scientific, Inc.
9.2.7.1 Overview
9.2.7.2 Financial performance
9.2.7.3 Strategic initiatives
9.2.7.4 Product benchmarking
9.2.8 Active Motif
9.2.8.1 Overview
9.2.8.2 Financial performance
9.2.8.3 Strategic initiatives
9.2.8.4 Product benchmarking
9.2.9 Zymo Research Corporation
9.2.9.1 Overview
9.2.9.2 Financial performance
9.2.9.3 Strategic initiatives
9.2.9.4 Product benchmarking
9.2.10 CellCentric
9.2.10.1 Overview
9.2.10.2 Strategic initiatives
9.2.10.3 Product benchmarking
9.2.11 Valirx
9.2.11.1 Overview
9.2.11.2 Financial performance
9.2.11.3 Strategic initiatives
9.2.11.4 Product benchmarking
9.2.12 Sigma-Aldrich Corporation (Merck KGaA)
9.2.12.1 Overview
9.2.12.2 Financial performance
9.2.12.3 Strategic initiatives
9.2.12.4 Product benchmarking
List of Tables TABLE 1 Global cancer cases, 2018 TABLE 2 Some major collaboration in epigenetic diagnostic market TABLE 3 List of key organizations funding epigenetics related R&D worldwide TABLE 4 North America Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 5 North America Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 6 North America DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 7 North America Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 8 North America Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 9 North America large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 10 North America microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 11 North America chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 12 North America Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 13 North America Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 14 North America Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 15 U.S. Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 16 U.S. Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 17 U.S. DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 18 U.S.Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 19 U.S.Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 20 U.S. large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 21 U.S.microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 22 U.S.chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 23 U.S.Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 24 U.S.Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 25 U.S.Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 26 Europe Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 27 Europe Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 28 Europe DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 29 Europe Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 30 Europe Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 31 Europe large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 32 Europe microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 33 Europe chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 34 Europe Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 35 Europe Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 36 Europe Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 37 U.K. Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 38 U.K. Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 39 U.K. DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 40 U.K. Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 41 U.K. Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 42 U.K. large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 43 U.K. microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 44 U.K. chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 45 U.K. Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 46 U.K. Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 47 U.K. Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 48 Germany Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 49 Germany Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 50 Germany DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 51 Germany Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 52 Germany Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 53 Germany large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 54 Germany microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 55 Germany chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 56 Germany Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 57 Germany Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 58 Germany Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 59 Spain Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 60 Spain Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 61 Spain DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 62 Spain Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 63 Spain Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 64 Spain large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 65 Spain microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 66 Spain chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 67 Spain Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 68 Spain Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 69 Spain Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 70 France Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 71 France Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 72 France DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 73 France Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 74 France Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 75 France large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 76 France microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 77 France chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 78 France Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 79 France Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 80 France Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 81 Italy Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 82 Italy Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 83 Italy DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 84 Italy Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 85 Italy Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 86 Italy large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 87 Italy microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 88 Italy chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 89 Italy Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 90 Italy Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 91 Italy Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 92 Russia Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 93 Russia Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 94 Russia DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 95 Russia Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 96 Russia Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 97 Russia large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 98 Russia microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 99 Russia chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 100 Russia Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 101 Russia Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 102 Russia Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 103 Asia Pacific Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 104 Asia Pacific Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 105 Asia Pacific DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 106 Asia Pacific Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 107 Asia Pacific Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 108 Asia Pacific large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 109 Asia Pacific microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 110 Asia Pacific chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 111 Asia Pacific Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 112 Asia Pacific Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 113 Asia Pacific Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 114 Japan Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 115 Japan Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 116 Japan DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 117 Japan Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 118 Japan Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 119 Japan large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 120 Japan microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 121 Japan chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 122 Japan Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 123 Japan Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 124 Japan Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 125 China Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 126 China Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 127 China DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 128 China Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 129 China Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 130 China large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 131 China microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 132 China chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 133 China Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 134 China Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 135 China Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 136 India Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 137 India Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 138 India DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 139 India Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 140 India Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 141 India large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 142 India microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 143 India chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 144 India Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 145 India Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 146 India Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 147 South Korea Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 148 South Korea Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 149 South Korea DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 150 South Korea Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 151 South Korea Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 152 South Korea large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 153 South Korea microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 154 South Korea chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 155 South Korea Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 156 South Korea Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 157 South Korea Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 158 Singapore Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 159 Singapore Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 160 Singapore DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 161 Singapore Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 162 Singapore Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 163 Singapore large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 164 Singapore microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 165 Singapore chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 166 Singapore Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 167 Singapore Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 168 Singapore Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 169 Australia Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 170 Australia Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 171 Australia DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 172 Australia Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 173 Australia Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 174 Australia large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 175 Australia microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 176 Australia chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 177 Australia Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 178 Australia Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 179 Australia Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 180 Latin America Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 181 Latin America Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 182 Latin America DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 183 Latin America Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 184 Latin America Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 185 Latin America large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 186 Latin America microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 187 Latin America chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 188 Latin America Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 189 Latin America Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 190 Latin America Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 191 Brazil Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 192 Brazil Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 193 Brazil DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 194 Brazil Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 195 Brazil Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 196 Brazil large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 197 Brazil microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 198 Brazil chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 199 Brazil Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 200 Brazil Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 201 Brazil Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 202 Mexico Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 203 Mexico Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 204 Mexico DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 205 Mexico Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 206 Mexico Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 207 Mexico large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 208 Mexico microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 209 Mexico chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 210 Mexico Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 211 Mexico Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 212 Mexico Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 213 Argentina Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 214 Argentina Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 215 Argentina DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 216 Argentina Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 217 Argentina Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 218 Argentina large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 219 Argentina microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 220 Argentina chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 221 Argentina Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 222 Argentina Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 223 Argentina Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 224 MEA Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 225 MEA Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 226 MEA DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 227 MEA Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 228 MEA Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 229 MEA large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 230 MEA microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 231 MEA chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 232 MEA Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 233 MEA Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 234 MEA Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 235 South Africa Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 236 South Africa Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 237 South Africa DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 238 South Africa Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 239 South Africa Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 240 South Africa large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 241 South Africa microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 242 South Africa chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 243 South Africa Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 244 South Africa Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 245 South Africa Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 246 UAE Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 247 UAE Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 248 UAE DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 249 UAE Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 250 UAE Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 251 UAE large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 252 UAE microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 253 UAE chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 254 UAE Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 255 UAE Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 256 UAE Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million) TABLE 257 Saudi Arabia Epigenetics Diagnostic Market, by Product 2014 - 2026 (USD Million) TABLE 258 Saudi Arabia Epigenetics Diagnostic Market, by Technology 2014 - 2026 (USD Million) TABLE 258 Saudi Arabia DNA Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 259 Saudi Arabia Histone Methylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 260 Saudi Arabia Histone Acetylation Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 261 Saudi Arabia large non-coding RNA Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 262 Saudi Arabia microRNA modification Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 263 Saudi Arabia chromatin structures Epigenetics Diagnostic Market, by Product, 2014 - 2026 (USD million) TABLE 264 Saudi Arabia Epigenetics Diagnostic Market, by Application 2014 - 2026 (USD Million) TABLE 265 Saudi Arabia Epigenetics Diagnostic Oncology Market, by Application 2014 - 2026 (USD Million) TABLE 266 Saudi Arabia Epigenetics Diagnostic Non-oncology Market, by Application 2014 - 2026 (USD Million)
List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Primary research pattern FIG. 4 Market research approaches FIG. 5 Value chain based sizing & forecasting FIG. 6 QFD modelling for market share assessment FIG. 7 Market summary FIG. 8 Market trends & outlook FIG. 9 Market segmentation & scope FIG. 10 Global epigenetics diagnostic market, 2014 - 2026 (USD Million) FIG. 11 Epigenetics Diagnostic Market driver relevance analysis (Current & future impact) FIG. 12 Global population by age group, 2000 - 2050 (in billion) FIG. 13 Population of age 60 years and above, by region (2017 & 2020) FIG. 14 Epigenetics Diagnostic Market restraint relevance analysis (Current & future impact) FIG. 15 Epigenetics key opportunities prioritized FIG. 16 SWOT Analysis, By Factor (political & legal, economic and technological) FIG. 17 Porter's Five Forces Analysis FIG. 18 Epigenetics diagnostic market product outlook key takeaways FIG. 19 Epigenetics diagnostic market: Product movement analysis FIG. 20 Epigenetics-based reagents estimates and forecast, 2014 - 2026 (USD Million) FIG. 21 Epigenetics-based kits estimates and forecast, 2014 - 2026 (USD Million) FIG. 22 ChIP sequencing kit Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 23 Whole-genomic amplification kit Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 24 Bisulfite conversion kit Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 25 RNA sequencing Kit Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 26 Others kit Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 27 Epigenetics-based instruments Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 28 Epigenetics-based enzymes Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 29 Epigenetics-based services market estimates and forecast, 2014 - 2026 (USD Million) FIG. 30 Epigenetics diagnostic market technology outlook key takeaways FIG. 31 Epigenetics diagnostic market: Technology movement analysis FIG. 32 Epigenetics-based DNA methylation market estimates and forecast, 2014 - 2026 (USD Million) FIG. 32 Epigenetics-based reagents estimates and forecast, 2014 - 2026 (USD Million) FIG. 33 Epigenetics-based kits estimates and forecast, 2014 - 2026 (USD Million) FIG. 34 Epigenetics-based instruments Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 35 Epigenetics-based enzymes Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 36 Epigenetics-based services market estimates and forecast, 2014 - 2026 (USD Million) FIG. 37 Epigenetics-based histone methylation market estimates and forecast, 2014 - 2025 (USD Million) FIG. 38 Epigenetics-based reagents estimates and forecast, 2014 - 2026 (USD Million) FIG. 39 Epigenetics-based kits estimates and forecast, 2014 - 2026 (USD Million) FIG. 40 Epigenetics-based instruments Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 41 Epigenetics-based enzymes Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 42 Epigenetics-based services market estimates and forecast, 2014 - 2026 (USD Million) FIG. 43 Epigenetics-based histone acetylation market estimates and forecast, 2014 - 2025 (USD Million) FIG. 44 Epigenetics-based reagents estimates and forecast, 2014 - 2026 (USD Million) FIG. 45 Epigenetics-based kits estimates and forecast, 2014 - 2026 (USD Million) FIG. 46 Epigenetics-based instruments Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 47 Epigenetics-based enzymes Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 48 Epigenetics-based services market estimates and forecast, 2014 - 2026 (USD Million) FIG. 49 Epigenetics-based long non-coding RNA market estimates and forecast, 2014 - 2025 (USD Million) FIG. 50 Epigenetics-based reagents estimates and forecast, 2014 - 2026 (USD Million) FIG. 51 Epigenetics-based kits estimates and forecast, 2014 - 2026 (USD Million) FIG. 52 Epigenetics-based instruments Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 53 Epigenetics-based enzymes Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 54 Epigenetics-based services market estimates and forecast, 2014 - 2026 (USD Million) FIG. 55 Epigenetics-based microRNA modification market estimates and forecast, 2014 - 2025 (USD Million) FIG. 56 Epigenetics-based Chromatin structures market estimates and forecast, 2014 - 2025 (USD Million) FIG. 57 Epigenetics-based reagents estimates and forecast, 2014 - 2026 (USD Million) FIG. 58 Epigenetics-based kits estimates and forecast, 2014 - 2026 (USD Million) FIG. 59 Epigenetics-based instruments Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 60 Epigenetics-based enzymes Market estimates and forecast, 2014 - 2026 (USD Million) FIG. 61 Epigenetics-based services market estimates and forecast, 2014 - 2026 (USD Million) FIG. 62 Epigenetics diagnostic market application outlook key takeaways FIG. 63 Epigenetics diagnostic market: Application movement analysis FIG. 64 Oncology market estimates and forecast, 2014 - 2026 (USD Million) FIG. 65 Solid tumors market estimates and forecast, 2014 - 2026 (USD Million) FIG. 66 Liquid tumors market estimates and forecast, 2014 - 2026 (USD Million) FIG. 67 Non-oncology disorders market estimates and forecast, 2014 - 2026 (USD Million) FIG. 68 Inflammatory diseases market estimates and forecast, 2014 - 2026 (USD Million) FIG. 69 Metabolic diseases market estimates and forecast, 2014 - 2026 (USD Million) FIG. 70 Infectious diseases market estimates and forecast, 2014 - 2026 (USD Million) FIG. 71 Cardiovascular diseases market estimates and forecast, 2014 - 2026 (USD Million) FIG. 72 Others market estimates and forecast, 2014 - 2026 (USD Million) FIG. 73 Epigenetics diagnostic market: Regional market place: Key takeaways FIG. 74 Epigenetics diagnostic market: Regional movement analysis FIG. 75 North America epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 76 U.S. epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 77 Canada epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 78 Europe epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 79 U.K. epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 80 Germany epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 81 Spain epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 82 France epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 83 Italy epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 84 Russia epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 85 Asia Pacific epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 86 Japan epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 87 China epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 88 India epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 89 South Korea epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 90 Singapore epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 91 Australia epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 92 Latin America epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 93 Brazil epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 94 Mexico epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 95 Argentina epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 96 MEA epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 97 South Africa epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 98 UAE epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 99 Saudi Arabia epigenetics diagnostic market estimates and forecast, 2014 - 2026 (USD Million) FIG. 100 Strategy framework
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
